These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5066 related articles for article (PubMed ID: 6212110)

  • 1. [Relation between immunogenicity and differentiation of metastasis in an experimental murine melanoma].
    Heinen E; Beckers J; Desaive C; Lennes G; Simar L
    C R Seances Soc Biol Fil; 1982; 176(2):223-6. PubMed ID: 6212110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of natural killer cells in tumor growth and metastasis: C57BL/6 normal and beige mice.
    Talmadge JE; Meyers KM; Prieur DJ; Starkey JR
    J Natl Cancer Inst; 1980 Nov; 65(5):929-35. PubMed ID: 6933263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
    Miner KM; Klostergaard J; Granger GA; Nicolson GL
    J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to intravenous tumor metastases in the athymic nude mouse: a paradoxic response.
    Richie JP; McDonald J; Gittes RF
    Surgery; 1981 Aug; 90(2):214-20. PubMed ID: 7256537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of immunogenicity with the poorly immunogenic B16 melanoma.
    Celik C; Lewis DA; Goldrosen MH
    Cancer Res; 1983 Aug; 43(8):3507-10. PubMed ID: 6861123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased immunogenicity of B16 melanoma clones selected for their ability to metastasize from a heterogeneous primary tumor.
    Steele GD; Richie JP; Wang BS; Mannick JA; Wilson RE
    Surg Forum; 1979; 30():132-3. PubMed ID: 538574
    [No Abstract]   [Full Text] [Related]  

  • 8. Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain meninges-colonizing murine B16 melanoma.
    Miner KM; Kawaguchi T; Uba GW; Nicolson GL
    Cancer Res; 1982 Nov; 42(11):4631-8. PubMed ID: 7127301
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis.
    Shi Q; Xiong Q; Wang B; Le X; Khan NA; Xie K
    Cancer Res; 2000 May; 60(10):2579-83. PubMed ID: 10825124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serologically detectable MHC and tumor-associated antigens on B16 melanoma variants and humoral immunity in mice bearing these tumors.
    Baniyash M; Smorodinsky NI; Yaakubovicz M; Witz IP
    J Immunol; 1982 Sep; 129(3):1318-23. PubMed ID: 7108209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of metastatic variants from heterogeneous tumor cell lines using the chicken chorioallantoic membrane and nude mouse.
    Dexter DL; Lee ES; DeFusco DJ; Libbey NP; Spremulli EN; Calabresi P
    Cancer Res; 1983 Apr; 43(4):1733-40. PubMed ID: 6831418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new melanoma model in C57BL/6 mice.
    Berkelhammer J; Oxenhandler RW; Hook RR; Hennessy JM
    Cancer Res; 1982 Aug; 42(8):3157-63. PubMed ID: 7093959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
    Stackpole CW; Demsey A
    Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenogeneic DNA immunization in melanoma models for minimal residual disease.
    Hawkins WG; Gold JS; Blachere NE; Bowne WB; Hoos A; Lewis JJ; Houghton AN
    J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
    Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
    Loveless SE; Munson AE
    Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma.
    Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN
    Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-3 polyunsaturated fatty acids accentuate B16 melanoma growth and metastasis through suppression of tumoricidal function of T cells and macrophages.
    Salem ML; Kishihara K; Abe K; Matsuzaki G; Nomoto K
    Anticancer Res; 2000; 20(5A):3195-203. PubMed ID: 11062743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 254.